Winter 2022/2023 Vol. 12 Issue 04
-
From the Editor-in-Chief
Taking Aim at CancerTherapeutic antibodies carry ‘payloads’ to destroy cancer cells.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Finding Light in Winter’s DarknessColder temperatures, gray skies and shorter days can dampen the spirits, which can heighten sadness associated with cancer treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
Creating Calm in ChaosA prepacked bag of essential and not-so-essential items can provide structure and comfort to people with cancer during treatment.
by K.J. Bannan
-
Policy Matters
Stemming the E-Cigarette EpidemicAn updated AACR-ASCO joint statement recommends steps for policymakers to lower e-cigarette use among youth and young adults.
by Roy S. Herbst, MD, PhD
-
Cervical Cancer: A Global Challenge
Low- and middle-income countries make inroads against a preventable and treatable cancer.
by Erin O’Donnell
-
Mysterious Microbes
Scientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
by Natalie Slivinski
-
An Ongoing Discussion
Physicians are often hesitant to bring up end-of-life care discussions with their patients. People being treated for cancer may need to frame questions to determine their own goals of care.
by Cameron Walker
-
Survivor Profile
Rising to the ChallengeJames R. Scott uses his experiences with bladder cancer to be a light for others.
by Lindsey Konkel Neabore
-
Q&A
The FDA’s Risk-Benefit FrameworkUsing the withdrawal of Avastin’s approval for breast cancer as a case study, Mikkael A. Sekeres’ new book analyzes the U.S. drug approval process.
by Marci A. Landsmann
-
Get Involved
Healing Takes FlightAlicia and Esther Tambe honor their sister’s memory by providing travel experiences to Black women diagnosed with breast cancer.
by Thomas Celona
-
Facts and Stats
Setting the StageUnderstanding your cancer’s stage is important for determining your prognosis and treatment options. Here’s what the different stages mean.
by Thomas Celona
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff